Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Chen

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Scientific Reports|December 1, 2021
In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathologyAditi Sahu, Yuna Oh, Gary Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647Steven B Gendreau, Richard Ventura, Paul Keast, et al.
Journal of Virology|January 12, 2022
Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion MorphogenesisBo Yang, YongXuan Yao, Han Cheng, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironmentSusanne M Steggerda, Mark K Bennett, Jason Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal CancerSandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell CarcinomaAditi Sahu, Jose Cordero, Xiancheng Wu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
DNA density is a better indicator of a nuclear bleb than lamin B lossSamantha Bunner, Kelsey Prince, Karan Srikrishna, et al.
American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 4, 2025
Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trialsRishabh Mahesh, Damien Hao Chen Wong, Vickram Vijay Anand, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Scientific Reports|December 1, 2021
In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathologyAditi Sahu, Yuna Oh, Gary Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647Steven B Gendreau, Richard Ventura, Paul Keast, et al.
Journal of Virology|January 12, 2022
Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion MorphogenesisBo Yang, YongXuan Yao, Han Cheng, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironmentSusanne M Steggerda, Mark K Bennett, Jason Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal CancerSandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell CarcinomaAditi Sahu, Jose Cordero, Xiancheng Wu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
DNA density is a better indicator of a nuclear bleb than lamin B lossSamantha Bunner, Kelsey Prince, Karan Srikrishna, et al.
American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 4, 2025
Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trialsRishabh Mahesh, Damien Hao Chen Wong, Vickram Vijay Anand, et al.
Pageof 26